Eculizumab Add-On Therapy in the Acute Phase of NMOSD: A Multicenter Prospective Real-World Study（ETA/PETA-NMOSD Study）

​ Conditions: Neuromyelitis Optica Spectrum Disorder Attack

Interventions: Drug: Eculizumab+IVMP; Drug: IVIG+IVMP; Drug: IVMP

Sponsors: Chinese PLA General Hospital

Not yet recruiting Conditions: Neuromyelitis Optica Spectrum Disorder Attack
Interventions: Drug: Eculizumab+IVMP; Drug: IVIG+IVMP; Drug: IVMP
Sponsors: Chinese PLA General Hospital
Not yet recruiting